STOP PRESS: Phase 2 data Patients receiving INV102 (nadolol) were more likely to stop smoking completely or dramatically reduce the number of cigarettes smoked INV102 (nadolol) significantly decreases key mucous metaplasia biomarker MUC5AC Invion requests FDA End of Phase 2 meeting and submits abstract to 2016 American Thoracic Society (ATS) annual meeting
Looks like the CR has been extended now to 7 Dec. 2015. Possibly a sign of low interest? or the company needs more time to really get the message out. Seems like comms are an afterthought.
- Forums
- ASX - By Stock
- Ann: Investor newsletter
IVX
invion limited
Add to My Watchlist
3.13%
!
9.9¢

STOP PRESS: Phase 2 data Patients receiving INV102 (nadolol)...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.9¢ |
Change
0.003(3.13%) |
Mkt cap ! $8.456M |
Open | High | Low | Value | Volume |
9.6¢ | 9.9¢ | 9.6¢ | $4.722K | 48.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 73355 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 49950 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73355 | 0.096 |
1 | 10000 | 0.095 |
1 | 47000 | 0.094 |
1 | 25000 | 0.093 |
1 | 42667 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 49950 | 1 |
0.100 | 178199 | 2 |
0.105 | 22413 | 3 |
0.110 | 28153 | 1 |
0.115 | 58455 | 2 |
Last trade - 13.17pm 01/08/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online